Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 29 Apr 2008):

Effect of levetiracetam on cortical excitability: a transcranial magnetic stimulation study.

Full Abstract

BACKGROUND AND PURPOSE: We studied the effect of levetiracetam (LEV), an anticonvulsant with a novel mechanism of action, on cortical excitability, measured using transcranial magnetic stimulation (TMS). For this purpose, 38 healthy volunteers were assessed in two TMS sessions, before and after an oral dose of 3000 mg LEV. METHODS: Resting motor threshold (RMT), intracortical facilitation (ICF) and intracortical inhibition (ICI), cortical silent period (CSP) threshold and duration and motor-evoked potential (MEP) amplitude were calculated. RESULTS: After treatment with LEV, RMT was increased (mean +/- SD: 63 +/- 14% of the maximum stimulator output) compared with baseline (58 +/- 11%). CSP threshold was decreased after LEV (54 +/- 10%; baseline, 57 +/- 11%). CSP duration was increased after LEV (116 +/- 37 ms; baseline: 102 +/- 33 ms). LEV did not affect ICF or ICI or mean MEP amplitude significantly. CONCLUSIONS: Our results indicate that LEV modulates some aspects of cortical excitability. Whereas the increase in the RMT most probably reflects the effect of LEV on ion channel activity, effects on the CSP might represent a modulation of GABA receptors at cortical and spinal level.

 

Author information

Author/s: Solinas, C (C); Lee, Y C (YC); Reutens, D C (DC);

Affiliation: Southern Clinical School, Monash University, Clayton, Vic., Australia.

Journal and publication information

Publication Type: Controlled Clinical Trial; Journal Article

Journal: European journal of neurology : the official journal of the European Federation of Neurological Societies (Eur J Neurol), published in England. (Language: eng)

Reference: 2008-May; vol 15 (issue 5) : pp 501-5

Dates: Created 2008/04/08; Completed 2008/06/12;

PMID: 18394048, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Nootropic Agents (0) ; etiracetam (33996-58-6) ; Piracetam (7491-74-9)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

8/4/1999
4/6/2008
Higher Relevance Score (37)
Lower Relevance Score (30)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy LLC 2003-2009 - All rights reserved. Terms of Use | Contact Us | Index